Effects of intracoronary diltiazem on no-reflow phenomenon after emergent percutaneous coronary intervention in patients with acute myocardial infarction

Journal of Central South University (Medical Sciences)

Volumn 31, Issue 6, 2006, Pages 917-920

  Zheng, Zhao Fen ^a   Pu, Xiao Qun ^a   Yang, Tian Lun ^a   Li, Chuan Chang ^a   Peng, Dao Di ^a   Yu, Zai Xin ^a   Mo, Long ^a   Chen, Xiao Bin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Diltiazem; Intracoronary stenting; No reflow phenomenon; Percutaneous transluminal coronary angioplasty

Indexed keywords

DILTIAZEM; UROKINASE;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTERY BLOOD FLOW; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; DRUG EFFECT; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; DILTIAZEM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; STENTS; TREATMENT OUTCOME;

EID: 33846282744     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Chinese source
2. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial [J]. N Engl J Med, 1985, 312(14): 932-936.
3. Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction [J]. J Am Coll Cardiol, 2000, 36(4):1202-1209.
4. Lepper W, Sieswerda G T, Vanoverschelde J L, et al. Predictive value of markers of myocardial reperfusion in acute myocardial infarction for follow - up left ventricular function [J]. Am J Cardiol, 2001, 88(12):1358-1363.
5. Jugdutt B I. Ventricular remodling after infarction and extracellar collagen matrix [J]. Circulation, 2003, 108(11): 1395-1403.
6. Resnic F S, Wainstein M, Lee M K, et al, No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention [J]. Am Heart J, 2003, 145(1):42-46.
7. Erbel R, Heusch G. Coronary microembolization [J]. J Am Coll Cardiol, 2000, 36(1):22-24.
8. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease [J]. Circulation, 2000, 101(5):570-580.
9. Henriques J P, Zijlstra F, Ottervanger J P, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction [J]. Eur Heart J, 2002, 23(14):1112-1117.
10. Ishihara M, Saito H, Tateishi H, et al. Effects of various dose of intracoronary diltiazem on coronary resistance vessels in humans [J]. Jpn Circ J, 1995, 59(7):790-798.
11. Wyrens F J, Mooney J, Lesser J, et al. Intracoronary diltiazem for microvascular spasm after interventional therapy [J]. Am J Cardiol, 1995, 75(12):849-850.